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1. Introduction 
Right ventricular (RV) hypertrophy is an adaptive response to chronic pulmonary 
hypertension, but can progress to chronic or advanced RV heart failure. The treatment of 
pulmonary hypertension is improving but remains unsatisfactory (Humbert et al., 2010). A 
better understanding of the transition from hypertrophy to RV failure may lead to new 
insights in the treatment of pulmonary hypertension.  
The increased workload of the right heart due to pulmonary hypertension increases oxygen 
consumption of right ventricular cardiomyocytes because the mitochondria have to operate 
at a higher rate. Hypertrophy can normalize right ventricular wall stress, thereby also 
normalizing the rate of oxygen consumption by mitochondria. However, hypertrophy may 
cause hypoxia in cardiomyocytes because intracellular diffusion distances for oxygen 
increase and capillary density decreases when the myocytes enlarge. Increased diffusion 
distances imply that the interstitial oxygen tension preventing core hypoxia in 
cardiomyocytes (PO2crit) increases, whereas reduced capillary density likely reduces 
interstitial PO2. In addition to the increased power output of the right ventricular myocytes, 
the rate of oxygen consumption of the cells also increases because their mechanical 
efficiency decreases (Wong et al., 2010). These changes can lead to oxidative stress (Redout 
et al., 2007) and may lead to apoptosis of RV cardiomyocytes (Ecarnot-Laubriet et al., 2002).  
Whether or not hypoxia occurs in hypertrophied cardiomyocytes is a matter of debate 
because measurement of core PO2 in cardiomyocytes in vivo is technically impossible. 
Previous reports, in which myoglobin saturation was measured to estimate mean 
intracellular PO2 in the left heart, suggest that hypoxic cores in cardiomyocytes are absent 
(Bache et al., 1999; Kreuzer et al., 2001). However, Hill et al. (1989) demonstrated that 
supplemental oxygen reduces hypertrophy in experimental pulmonary hypertension. 
We use calibrated histochemistry to obtain the physiological parameters required to 
evaluate oxygen demand and supply at the cellular level in hypertrophied right ventricular 
myocardium of pulmonary hypertensive rats (des Tombe et al., 2002). To investigate 
whether the cardiomyocytes adapt to hypoxia, we determined the expression of the hypoxia 
inducible transcription factor HIF 1 (Wang & Semenza, 1995) by quantitative 
immunohistochemistry in cardiomyocyte nuclei. 
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2. Calculation of PO2’s 
The mean extracellular oxygen tension required to drive oxygen from the interstitial space 
into cardiomyocytes preventing hypoxic cores (PO2crit) is calculated from a Hill-type 
diffusion model including myoglobin-facilitated diffusion (Murray, 1974):  
 PO2crit = (VO2max CSA - 4πDMb[MbO2]R)/4πKO2   (1)  
where VO2max is the maximum rate of oxygen consumption of the cardiomyocyte, CSA is the 
cross-sectional area of the cardiomyocyte, DMb is the radial diffusion coefficient of 
myoglobin in the cardiomyocyte, [MbO2]R is the concentration of oxygenated myoglobin at 
the sarcolemma of the cardiomyocyte and KO2 is Krogh’s diffusion coefficient for oxygen in 
heart muscle. [MbO2]R can be calculated from: 
 [MbO2]R = PO2crit Mbtot/(PO2crit + P50) (2) 
where Mbtot is the total myoglobin concentration in the cardiomyocyte and P50 is the oxygen 
tension at which 50% of myoglobin is oxygenated. Substitution of equation 2 into equation 1 
allows the calculation of PO2crit. CSA, VO2max and myoglobin concentration were determined 
as described below. The values for the other parameters were taken from the literature:  
DMb = 2.0 10-5 mm2 s-1 (Papadopoulos et al., 2001), KO2 = 1.5 nM mm2 s-1 hPa-1 (van der 
Laarse et al., 2005), and P50 = 8.7 hPa. The latter value was calculated from P50 of rat 
myoglobin and the temperature dependency of P50 (Gayeski & Honig, 1991; Enoki et al., 
1995; Schenkman et al., 1997). 
Assuming that oxygen supply is limiting VO2max by a negligible percentage in normal 
muscle (Spriet et al., 1986; Mootha et al., 1997), it is possible to calculate the permeability of 
the capillary endothelium and the interstitial space for oxygen using Fick’s law, because in 
the steady state the flux of oxygen entering the cardiomyocytes equals the flux of oxygen 
crossing the capillary endothelium. This flux per unit myocyte length is: 
 CSA VO2max = Dcap (PO2cap-PO2crit)                             (3) 
where Dcap is the permeability of capillary endothelium and interstitial space (in nmol  
mm-1myocyte s-1 hPa-1), and PO2cap is the average capillary oxygen tension. PO2cap-PO2crit is the 
minimum driving force required to prevent hypoxia in the cardiomyocytes. The average 
capillary PO2 used in the calculation in normal myocardium is 66 hPa, which equals P50 of 
rat blood (Schmidt-Nielsen & Larimar, 1958; Gray & Steadman, 1964) and approximates the 
mean of capillary arterial and venous PO2. We assume that Dcap is proportional to the 
number of capillaries per cardiomyocyte (for discussion, see Bekedam, 2010). The 
permeability in normal myocardium was used to calculate PO2cap in hypertrophied 
myocardium, taking changes in CSA VO2max, capillaries per cell and PO2crit into account. 
3. Animals and histochemical methods 
3.1 Preparations 
All experiments were approved by the local Animal Ethics Committee. Male Wistar rats  
(n = 33) were used for this study. At 180 g body mass, 18 rats were injected s.c. with 40 mg 
monocrotaline (MCT) per kg body mass, to induce pulmonary hypertension (Okumura et 
al., 1992). Body mass was determined daily. The body mass change (in %/day) was 
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calculated as the mean of the last three days. Untreated, age-matched rats served as controls. 
Right ventricular systolic pressure of monocrotaline-injected rats in our laboratory increases 
after the injection from 25 (SEM 0.9) mmHg in control (CNTR) to 45 (SEM 4.6) mmHg after 
two weeks (MCT2) and to 64 (SEM 2.8) mmHg after 4 weeks (MCT4, Henkes et al., 2007). 
We did not measure pulmonary arterial pressure in the rats used in the present experiments 
because the measurement and the anaesthesia may interfere with HIF 1α expression (YY 
Wong and WJ van der Laarse, unpublished results). After 2 or 4 weeks, 6 or 12 MCT rats 
and 6 or 9 control rats, respectively, were anaesthetized with halothane and the lungs and 
heart were excised. The heart was perfused with Tyrode solution (120 mM NaCl, 5 mM KCl, 
1.2 mM MgSO4, 2.0 mM Na2HPO4, 27 mM NaHCO3, 1 mM CaCl2, 10 mM glucose and 20 
mM 2,3-butanedione monoxime, equilibrated with 95% O2 and 5% CO2; pH 7.3-7.4 at 10oC) 
to slow down metabolism and remove the blood and a biopsy was taken from the right 
ventricular wall within 10 min after excision. The biopsy was frozen in liquid nitrogen (van 
der Laarse & Diegenbach, 1988). Sections, 5 m thick, were cut in a cryostat, air-dried for  
30 min and incubated for succinate dehydrogenase (SDH) activity or stored at -80oC until 
use. The wet mass of the lungs and the dry mass after freeze-drying were determined.  
3.2 Calibrated enzymehistochemistry  
SDH activity was demonstrated as described (des Tombe et al., 2002). The incubation 
medium consisted of 37.5 mM sodium phosphate buffer, pH 7.6, 75 mM sodium succinate,  
5 mM sodium azide, and 0.4 mM tetranitro blue tetrazolium. Sections were incubated at 
37oC in the dark for 7 min. To calculate the extracellular oxygen tension required to  
prevent a hypoxic core in the cardiomyocyte (PO2crit), an estimate of VO2max (in nmol mm-3  
s-1 = mM s-1) was calculated from the absorbance of the formazan precipitate measured in 
the section, based on the proportional relationship between VO2max and SDH activity under 
hyperoxic conditions in vitro: VO2max = 2.9 mM s-1 per unit of absorbance at 660 nm (des 
Tombe et al., 2002; van der Laarse et al., 2005).  
The sections for the determination of the myoglobin concentration and cytosolic cytochrome 
c were vapour-fixed with formaldehyde as described (van Beek-Harmsen et al., 2004, van 
Beek-Harmsen & van der Laarse, 2005). Myoglobin peroxidase activity was determined as 
described (Lee-de Groot et al., 1998), in a medium consisting of 59 ml 50 mM 
Tris(hydroxymethyl)aminomethane and 80 mM KCl, pH 8.0, 25 mg ortho-tolidine (Sigma 
T8533, St Louis, MI) dissolved in 2 ml 96% ethanol (at 50oC) and 1.43 ml 70% tertiary-butyl-
hydroperoxide (Fluka Chemie 19995, Buchs, Switzerland). The myoglobin concentration 
was determined using gelatine sections with known concentrations of myoglobin.  
The concentration was calculated from the absorbance using an extinction coefficient of  
363 mM-1 cm-1 (van Beek-Harmsen et al., 2004). 
3.3 Immunohistochemistry of HIF 1α, cytochrome c, and collagen type IV 
Incubations were carried out at room temperature (22-25oC). Sections for HIF 1α and 
collagen type IV were fixed in 4% formaldehyde in 150 mM NaCl, 10 mM Na2HPO4, 1.5 mM 
KH2PO4 (PBS), pH 7.4, for 10 min. sections for cytochrome c were fixed as indicated above. 
Sections were incubated with 1:100 dilution of anti-HIF 1α (H-206, Santa Cruz 
Biotechnology, Santa Cruz, CA), anti-collagen type IV (Rockland, Gilbertsville PA), or anti-
cytochrome c (Santa Cruz) for 1h, followed by incubation with a secondary biotin-labelled 
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anti-rabbit antibody in a 1:100 dilution (Vector Laboratories, Burlingame, CA) for 30 min. 
Endogenous peroxidase activity was quenched using 0.3% hydrogen peroxide in methanol 
for 30 min. Subsequently, following the manufacturers guidelines, the sections were 
incubated with Vectastain ABC reagent (Vector Laboratories). Each step was followed by 
rinsing in PBS containing 0.05% (v/v) Tween 20. Peroxidase activity was demonstrated in a 
solution containing 3 mg 3,3’-diaminobenzidine in 30 µl dimethyl sulphoxide, 10 ml 0.05 M 
Tris(hydroxymethyl)aminomethane, 10 mM imidazole and 10 mM sodium azide, pH 7.6. 
Hydrogen peroxide was added before use (final concentration 0.003%). 
3.4 Microdensitometry and morphometry 
Staining intensities and morphometry were quantified using a DMRB microscope (Leica, 
Wetzlar, Germany) fitted interference filters at 660 nm for SDH activity (Pool et al., 1979) 
and 436 nm for myoglobin (Lee-de Groot et al., 1998), cytochrome c (van Beek-Harmsen et 
al., 2005), and HIF 1α. Images were obtained using a 40x objective, and a monochrome 
Charge-Coupled Device camera (Sony XC 77CE, Towada, Japan), connected to a LG-3 frame 
grabber (Scion, Frederick, MD) in an Apple Macintosh computer. Images were analysed 
using NIH Image 1.61 (http://rsb.info.nih.gov/nih-image/). Grey values were transformed 
to absorbance values using calibrated grey filters. Morphometry was calibrated using a slide 
micrometer taking the pixel to aspect ratio into account. 
Cytochrome c release in cardiomyocytes or in the interstitial space was categorized as 0: no 
release, 1: some release in one or two areas of the section, 2: maximum release in more than 
two areas of the section, 3: maximum release detectable in the entire section. 
HIF 1α was measured by using the threshold option in NIH Image to measure the 
absorbance and size of the stained nuclei. The total staining of a nucleus was calculated as 
the product of absorbance and size. The mean absorbance of positive nuclei was multiplied 
by the fraction of positive nuclei to obtain the mean HIF 1α expression in the heart. 
The number of capillaries per cardiomyocyte was determined after incubation with anti-
collagen type IV (Madsen & Holmskov, 1995) in two areas of a section where 
cardiomyocytes were cut perpendicularly to their longitudinal axis.  
The sarcomere length was determined using a 100x phase contrast objective in areas of the 
section where the cardiomyocytes were cut along their longitudinal axis. This value was 
used to normalise the cross-sectional area to a sarcomere length of 2 μm, assuming that the 
volume of cardiomyocytes does not change when the cells contract. The volume of 
cytoplasm per nucleus was determined in sections fixed for 10 min in 4% formaldehyde in 
0.1 M sodium phosphate buffer, pH 7.4, and stained with hematoxylin and eosin  (Loud & 
Anversa, 1984; des Tombe et al., 2002). The number of cardiomyocyte nuclei in the right 
ventricular free wall was determined from the volume of the wall (calculated as wet 
mass/1.04). The volume of interstitial space was subtracted, and the volume occupied by 
cardiomyocytes was divided by the volume of cytoplasm per nucleus to obtain the number 
of cardiomyocyte nuclei. 
3.5 Statistics 
Values are given as mean (standard deviation, SD). Students t-test with equal or unequal 








4.1 Lung and body mass 
Fig. 1 shows lung masses and the change in body mass of control and MCT-injected rats. 
The wet mass of the lung was slightly but significantly increased after two weeks, as was the 
change in body mass. The wet/dry mass of the lung in MCT2 was higher than control 5.64 
(SD 0.42) and 5.22 (SD 0.34), respectively, indicating oedema in MCT2. The wet/dry mass of 
MCT4 rats was intermediate between control and MCT2 (5.33, S.D. 0.31; not different from 
control or MCT2). After 4 weeks, both wet and dry lung mass were significantly higher than 
control and MCT2, and the body mass decreased by 2% per day on average. However, the 
change in body mass in MCT4 rats was rather variable, as indicated by the large standard 
deviation (Fig. 1C); the range was +3.0 to –8.5 %per day. 
The changes in lung and body mass are indicative of the severity of pulmonary 
hypertension (Mouchaers et al., 2007; Handoko et al, 2009). 
 
 
Fig. 1. A: Lung wet mass, B: lung dry mass and C: body mass change of control and 
monocrotaline-injected rats after 2 (MCT2) and 4 (MCT4) weeks. The body mass change is 
the mean value over the last three days. * P<0.05, ** P<0.01, *** P<0.001: difference between 
MCT and control. +++ P<0.001: difference between MCT2 and MCT4. Controls at 2 and 4 
weeks are similar and were pooled. 
4.2 Right myocardial histology and histochemistry 
The histology is shown in Fig 2. Hematoxylin and eosin staining clearly shows hypertrophy 
of cardiomyocytes of the MCT4 rat, and also shows considerable heterogeneity of the cross-
sectional area of cardiomyocytes in the hypertrophic heart and many interstitial cells, which 
are leucocytes (Handoko et al. 2009). 
SDH activity was distributed fairly evenly in controls whereas it clusters in hypertrophic 
heart. Myoglobin shows a similar distribution as SDH activity in control and hypertrophic 
hearts. This staining was lost when sections were preincubated in saline before fixation, 
indicating that the peroxidase activity is not structurally bound (result not shown).  
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Fig. 2. Sections of a control and of a MCT-injected rat after 4 weeks. A,D: hematoxylin and 
eosin; B,E: SDH activity; C,F: Myoglobin concentration, G,J: Collagen type IV (capillaries); 
H,K: HIF 1α expression; black arrow heads point at cardiomyocyte nuclei, white arrow 
heads point at nuclei in interstitial cells; I,L: cytochrome c. Top and third row: control; 
second and bottom row: MCT4. Bar 50 μm. 
The sections incubated for collagen type IV show a decrease of capillary density expressed 
per unit of area in the hypertrophic heart, indicating that maximum oxygen supply per 
unit mass of the hypertrophic myocardium was reduced, and intracellular diffusion 
distances were increased. HIF 1α staining was very weak in control cardiomyocyte nuclei, 
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Cytochome c release was absent in controls. In MCT rats, cytochrome c was detected in a 
variable fraction of RV cardiomyocytes and could also be present in the interstitial space.  
4.3 Oxygen demand and supply 
The oxygen demand of the right heart can increase threefold due to the increase in 
pulmonary artery pressure (Handoko et al., 2009) and by a similar factor due to a decrease 
of mechanical efficiency (Wong et al., 2010). Fig. 3 shows the parameters relevant to oxygen 
demand and supply. Four weeks after monocrotaline the mean cross-sectional area of 
cardiomyocytes was significantly increased, whereas the mean SDH activity was similar to 
control. The maximum rate of oxygen uptake per unit of cardiomyocyte length (VO2maxCSA, 
in pmol mm-1 s-1) was increased, whereas the myoglobin concentration was slightly 
decreased in MCT4. These changes increased PO2crit. The number of capillaries per 
cardiomyocyte in MCT4 is slightly higher compared to MCT2, but not different from 
control. 
 
Fig. 3. Right ventricular cardiomyocyte characteristics of control rats (CNTR) and monocrotaline-
injected rats after 2 (MCT2) and 4 weeks (MCT4). A: cardiomyocyte cross-sectional area (CSA);  
B SDH activity given as absorbance value at 660 nm; C: oxygen uptake per mm cardiomyocyte, 
calculated from data in A and B; D: myoglobin concentration; E: PO2crit (see text); F: the number 
of capillaries per cardiomyocyte. * P<0.05, * P<0.001: difference between MCT and control;  
+ P<0.05, +++ P<0.001: difference between MCT2 and MCT4. 
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Fig. 4. PO2crit of individual cardiomyocytes of 12 control rats (upper panel), and 12 MCT4 
rats (middle panel), and required capillary PO2 in the MCT 4 rats (lower panel). 12 control 
rats were randomly selected and sorted by ascending mean PO2crit. PO2crit of 20  
cardiomyocytes in each rat are shown, also sorted by ascending PO2crit. PO2crit was calculated 
using equations 1 and 2. This value was used to calculate the mean capillary PO2 required to 
prevent hypoxia in MCT4 cardiomyocytes using CSA VO2max, PO2crits from the middle panel, 
and the number of capillaries per cardiomyocyte (see text). 
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Fig. 4 shows the distributions of PO2crit of individual cardiomyocytes. Individual rats 
differed with respect to PO2crit, with mean PO2crit ranging from 1.2 to 5.7 hPa; the overall 
mean was 2.8 hPa in control. In MCT4 rats, mean PO2crit increased to 5.7 hPa mainly due to 
an increase in myocyte cross sectional area and slightly due to a decrease of the myoglobin 
concentration (Fig 3AD). However, the lowest PO2crit values found in MCT4 rats were within 
the normal range observed in controls. The hypertrophic process increased the range of 
PO2crit in MCT4 rats considerably, from 2 to 16 hPa. The control rats were used to calculate 
capillary permeability using Fick’s law (equation 3). The permeability for oxygen 
normalised by the number of capillaries per myocyte (Fig. 3F) equalled 1.31 (SEM 0.17) fmol 
mm-1cap s-1 hPa-1. This value was used to calculate mean capillary PO2 in MCT4 rats. It can be 
inferred from the lower panel of Fig. 4 that a substantial fraction of the cardiomyocytes 
becomes hypoxic when the mitochondria are maximally activated and mean capillary PO2 
equals 66 hPa. The highest required capillary PO2’s found in MCT4 rats are well above 
normal arterial PO2 (about 133 hPa), indicating that the risk of oxygen supply limitation is 
substantial in MCT4 rats, especially during exercise. 
4.4 Cytosolic cytochrome c and the number of cardiomyocyte nuclei 
It can be expected that the cardiomyocytes try to adapt to hypoxia. Indeed, Fig. 5 shows that 
HIF 1α in cardiomyocyte nuclei was significantly increased in MCT4. Cytosolic cytochrome 
c was detected in cardiomyocytes of one out of six MCT2 rats and in nine out of twelve 
MCT4 rats. Interstitial cytochrome c was detected in two MCT2 rats and in eight MCT4 rats, 
indicating that HIF 1α expression cannot prevent mitochondrial dysfunction. Release of 
cytochrome c can lead to apoptosis of cardiomyocytes, but surprisingly the numbers of 
cardiomyocyte nuclei in the right ventricular free wall of control and experimental groups 
were similar. 
4.5 Correlation analyses 
Correlation analyses were carried out on the mean values of the parameters measured in 
MCT-injected animals, 2 and 4 weeks pooled (n = 18).  As shown in Fig 4B, the correlation of 
HIF 1α expression and PO2crit is significant (r = 0.64, P=0.004) but the explained variance of 
HIF 1α expression only 41% (r2 = 0.41). The change of body mass - a decrease of body mass 
is indicative of the severity of heart failure in MCT injected rats - correlated with volume of 
cytoplasm per cardiomyocyte nucleus (r = -0.48, P = 0.046), lung wet mass (r = -0.74, P 
<0.001) and lung dry mass (r = -0.79, P<0.001).  
HIF 1α expression correlated strongly with the coefficient of variation of spatially integrated 
SDH activity (or VO2maxCSA, Fig 3C: r = 0.80, P <0.001), indicating an increase of HIF 1α 
expression with an increase of the variability of the maximum oxygen consumption per 
myocyte. There were no correlations between cytosolic cytochrome c or the presence of 
cytochrome c in the interstitial space and PO2crit or HIF 1α expression. 
5. Discussion 
5.1 Hypoxic cores in hypertrophied cardiomyocytes 
The results demonstrate heterogeneous responses of most myocardial parameters to MCT-
induced pulmonary hypertension, not only between rats within experimental groups, but 
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also between individual cardiomyocytes in a heart. The heterogeneity indicates that 
individual cardiomyocytes react differently to MCT-induced increased workload. 
Furthermore, the heterogeneity is strongly related to HIF 1α expression. PO2crit increases in 
most MCT rats, and correlates with the expression of HIF 1α in nuclei of cardiomyocytes. 
The upper value of PO2crit is similar to coronary sinus PO2 during maximum exercise, 20 hPa 
(swine: Merkus et al., 2003; dog: Tune et al., 2004). End capillary venous PO2 in the RV  
myocardium of MCT rats is not known. It can be lower than 20 hPa, because myocardial 
blood flow is heterogeneous (Zuurbier et al., 1999), arterial PO2 in awake, freely moving 
MCT rats is reduced (to 88 ± 7 hPa (Hill et al., 1989), and because interstitial PO2 must be 
lower than capillary PO2 to extract oxygen. The present results provide an explanation for 
reduced survival induced by training in progressive pulmonary hypertensive rats (Handoko 
et al., 2009), because repeated increases of the workload of the right ventricle can lead to 
hypoxia-reoxygenation injury. 
 
Fig. 5. A: Expression of HIF 1α in arbitrary units (a.u.) in nuclei of right ventricular 
cardiomyocytes of control (CNTR) and monocrotaline-injected rats after 2 (MCT2) and 4 
(MCT4) weeks. B: HIF 1α expression in individual rats related to PO2crit. ○: control,  
▲: MCT2; ♦ MCT4, C: cytochrome c detected in cardiomyocyte cytoplasm; all 15 controls  
are negative; D: the number of cardiomyocyte nuclei in the right ventricular free wall;  
E: interstitial space; F: presence of cytochrome c in interstitium. * P<0.05: difference from 
control, + P<0.05: different from MCT2. 
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5.2 Oxygen consumption and cytochrome c release 
The effect of cytochrome c release on the rate of oxygen consumption and PO2crit is not 
known. We previously found (van der Laarse et al., 2005) that the maximum rate of oxygen 
consumption of myocardial trabecula dissected from the right ventricular wall of MCT4 rats 
is not different from control, whereas the rate of oxygen consumption at rest is much higher 
than control. It is a possibility that the high rate of oxygen consumption of quiescent 
hypertrophied trabeculae is due to cytochrome c release because cytosolic cytochrome c can 
oxidize cytosolic NADH (La Piana et al., 2005). This will reduce the efficiency of metabolic 
recovery, i.e. lower ATP/O2. It is unlikely therefore, that the release of cytochrome c would 
cause a decrease of VO2max and PO2crit in failing myocardium. It is a possibility that 
mitochondrial damage is the reason for the reduced mechanical efficiency in observed in 
papillary muscles (Wong et al., 2010). 
Bache et al. (1999) concluded that changes in energy rich phosphate concentrations that 
occur during high workload of hypertrophic hearts were not due to limited myocardial 
oxygenation using 1H nuclear magnetic resonance to monitor myoglobin desaturation in situ 
in the anaesthetised dog. In these studies, however, coronary sinus PO2 was about 40 hPa. 
Because this PO2 is twice the value measured in exercising animals (see above), it is not 
surprising that myoglobin remained saturated with oxygen in these experiments. This 
argument may also hold for a similar study in normal rat myocardium by Kreutzer et al. 
(2001), in which coronary sinus oxygen content was 2.8 mM during dopamine infusion (34% 
of control, corresponding to PO2 = 44 hPa; Gray et al., 1964). 
The release of cytochrome c from the mitochondria is a first sign of failure of 
cardiomyocytes to adapt to overload. It could already be observed two weeks after the 
monocrotaline injection when hypertrophy started to develop. We did not identify a single 
factor or a combination of factors that could fully explain the release, possibly because 
relevant factors were excluded in the analyses. For instance, arterial PO2 was not taken into 
account and interstitial cytochrome c may have been removed from the heart by lymph or 
blood (Radhakrishnan et al., 2007). 
5.3 Cytochrome c release and the number of cardiomyocyte nuclei 
The amount of cytochrome c released in different cardiomyocytes in one heart can vary 
from no to total release (van Beek-Harmsen & van der Laarse, 2005). Cytochrome c release 
did not induce apoptosis judging from the number of cardiomyocyte nuclei in the right 
ventricular free wall. This is surprising because we previously found a 40% decrease of the 
number of cardiomyocyte nuclei (des Tombe et al., 2002). Ecarnot-Laubriet et al. (2002) 
found apoptotic nuclei in the right ventricular myocardium of MCT-injected Wistar rats 
after 3 weeks but used a 1.5 times higher dose, 60 mg MCT/kg body mass. The reason for 
not finding a reduction of the number of cardiomyocyte nuclei in the present study could be 
that the occurrence of apoptosis in MCT-injected rats is dose-dependent and critically 
depends on type of rat strain, and food and housing conditions. This requires further study. 
We conclude that in the present experiments apoptosis is not the cause of the transition from 
hypertrophy to heart failure. 
5.4 Myoglobin 
The myoglobin concentration in hypertrophied cardiomyocytes decreased. It may be that 
the capacity to synthesize myoglobin (e.g. the increased cytoplasm/nucleus ratio or the 
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availability of iron (Rohbach et al., 2007) is the limiting factor, or that degradation of 
myoglobin in hypertrophied cardiomyocytes is increased, e.g. due to H2O2 production. We 
previously found higher myoglobin concentrations in hyperthyroid rats compared to MCT-
injected rats (Lee-de Groot et al., 1998). 
Transcription of the myoglobin gene is thyroid hormone (Gianocco et al., 2004) and vascular 
endothelial growth factor (VEGF) dependent (van Weel et al., 2004). Myocardial overload 
can lead to a hypothyroid state due to induction of deiodinase (Simonides et al., 2008), while 
VEGF expression is regulated by HIF 1α. (Forsythe et al., 1996). It has been shown that HIF 
1α  in pressure overloaded mouse heart can be inhibited by p53 (Sano et al., 2007). Whether 
or not p53 plays a role in the monocrotaline-induced pulmonary hypertension model 
remains to be investigated. Myoglobin mRNA is reduced in dog and bovine dilated 
myocardium (O’Brien et al., 1995; Weil et al, 1997), but is increased in pressure overloaded 
mouse heart (Lindsey et al., 2007). These results indicate that myoglobin expression may 
critically depend on different types of interacting factors. Increasing the myoglobin 
concentration in hypertrophied cardiomyocytes is an important therapeutic target because it 
can lower PO2crit  and thereby increase oxygen extraction from capillaries. 
5.5 Limitations 
The values of PO2crit and PO2cap presented above are underestimates because the model 
calculation of PO2crit assumes zero-order kinetics. Rumsey et al. (1990) showed that the 
Michaelis constant for oxygen of isolated rat heart mitochondria is 0.45 hPa at rest. 
However, any deviation from zero-order kinetics increases PO2crit, impairing oxygen 
extraction from capillaries. The Michaelis constant may also increase due to inhibition of 
complex IV by nitric oxide (Cooper & Brown, 2008). This could increase intracellular PO2 at 
the expense of reduced ADP phosphorylation and cardiac output. The calculation of 
capillary and interstitial permeability is based on assuming a reasonable mean capillary PO2 
but this permeability has not been verified. The calculation of capillary PO2 in MCT4 rats is 
based on the assumption that capillary permeability in control and pulmonary hypertensive 
rats is the same. This is a simplification because capillary circumference may increase, 
thereby increasing the endothelial diffusion area, whereas the permeability can decrease 
because the capillary basement menbrane thickens. These changes require further study and 
direct measurements of capillary permeability for oxygen are required. The translation of 
the present results to clinical applications will require the demonstration of similar changes 
in pulmonary hypertensive patients. Preliminary results indicate that this is the case (van 
Beek-Harmsen et al., 2007;  Ruiter et al., 2011). 
5.6 Conclusions 
We conclude that hypertrophying cardiomyocytes in MCT-injected pulmonary hypertensive 
rats adapt to hypoxia. However, the changes observed in the hypertrophied myocardium of 
MCT rats will lead to hypoxic cores in cardiomyocytes with high VO2maxCSA or PO2crit when 
the mitochondria are maximally activated. The adaptation cannot prevent cytochrome c 
release from mitochondria. The results indicate that an increase of the number of capillaries 
per cardiomyocyte is required to normalize the oxygen supply/demand ratio in the 
hypertrophied RV myocardium and that an increase of the myoglobin concentration is 
required to normalize PO2crit. When PO2crit cannot be normalized, interstitial PO2 has to 
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increase to prevent core hypoxia in hypertrophied cardiomyocytes, or intramyocyte 
capillaries (Kobayashi et al., 1999) have to be  induced. 
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